                               SEQUENCE LISTING

<110> UNIVERSITY OF KANSAS
      UNIVERSITY OF SOUTHERN CALIFORNIA
 
<120> MITIGATION OF PERI-IMPLANTITIS BY DESIGN AND STABILITY OF 
      BIFUNCTIONAL PEPTIDES WITH ANTIMICROBIAL PROPERTIES

<130> 104434-0217

<140> PCT/US2020/049621
<141> 2020-09-07

<150> 62/897,355
<151> 2019-09-08

<160> 7     

<170> PatentIn version 3.5

<210> 1
<211> 42
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 1
Arg Pro Arg Glu Asn Arg Gly Arg Glu Arg Gly Leu Gly Ser Gly Gly 
1               5                   10                  15      


Gly Lys Trp Lys Leu Trp Lys Lys Ile Glu Lys Trp Gly Gln Gly Ile 
            20                  25                  30          


Gly Ala Val Leu Lys Trp Leu Thr Thr Trp 
        35                  40          


<210> 2
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Gly Ser Gly Gly Gly 
1               5   


<210> 3
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Arg Pro Arg Glu Asn Arg Gly Arg Glu Arg Gly Leu 
1               5                   10          


<210> 4
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Lys Trp Lys Leu Trp Lys Lys Ile Glu Lys Trp Gly Gln Gly Ile Gly 
1               5                   10                  15      


Ala Val Leu Lys Trp Leu Thr Thr Trp 
            20                  25  


<210> 5
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Gly Lys Ile Ile Lys Leu Lys Ala Ser Leu Lys Leu Leu 
1               5                   10              


<210> 6
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 6
Arg Pro Arg Glu Asn Arg Gly Arg Glu Arg Gly Leu Gly Ser Gly Gly 
1               5                   10                  15      


Gly Gly Lys Ile Ile Lys Leu Lys Ala Ser Leu Lys Leu Leu 
            20                  25                  30  


<210> 7
<211> 43
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 7
Arg Pro Arg Glu Asn Arg Gly Arg Glu Arg Gly Leu Gly Ser Gly Gly 
1               5                   10                  15      


Gly Lys Trp Lys Leu Trp Lys Lys Ile Glu Lys Trp Gly Gln Gly Ile 
            20                  25                  30          


Gly Ala Val Leu Lys Trp Leu Thr Thr Trp Leu 
        35                  40              


